SS
ALZN icon

SBI Securities’s Alzamend Neuro ALZN Stock Holding History

SBI Securities’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26 Hold
22
– – ﹤0.01% 3789
2026
Q1 		$23 Hold
22
– – ﹤0.01% 3735
2025
Q4 		$40 Hold
22
– – ﹤0.01% 3624
2025
Q3 		$52 Hold
22
– – ﹤0.01% 3701
2025
Q2 		$64 Buy
22
+20
+1,000% +$99 ﹤0.01% 3665
2025
Q1 		$17 Hold
2
– – ﹤0.01% 3882
2024
Q4 		$21 Buy
+2
New +$26 ﹤0.01% 3821

Other funds holding ALZN

KWM
KMT Wealth Management El Segundo, California $118M AUM 26.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

SBI Securities's ALZN Position: Q2 2026 in Review

SBI Securities held its Alzamend Neuro (ALZN) position steady in Q2 2026 at 22 shares worth $26. The position accounts for ﹤0.01% of the portfolio, ranked #3789.

SBI Securities first reported a position in ALZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $64 in Q2 2025. 5 funds tracked by Wall St. Rank hold ALZN as of Q2 2026.

  • SBI Securities held 22 shares of Alzamend Neuro worth $26 as of Q2 2026.
  • SBI Securities left its Alzamend Neuro share count unchanged in Q2 2026.
  • Alzamend Neuro made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3789 holding.
  • SBI Securities first reported a position in Alzamend Neuro in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Alzamend Neuro position peaked at $64 in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Alzamend Neuro as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.